Literature DB >> 35936605

Cerebral Malaria, COVID-19 and Complete Blood Examination.

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2022        PMID: 35936605      PMCID: PMC9350752          DOI: 10.4103/aian.aian_839_21

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.714


× No keyword cloud information.
Dear Editor, We read the report by Ram et al.[1] with great interest. Ram et al.[1] reported on the co-occurrence of COVID-19 and malaria and concluded that “Every suspected case of COVID encephalitis has to be investigated for all possible causes …….” In the present report, it is likely that there is a problem in the first complete blood count examination. In laboratory medicine, a blood smear examination should be routinely done, and it is usually neglected when an automated hematology analyzer is widely used. Because the incubation period for COVID-19 (14 days) and cerebral malaria (12 days) can overlap, it is no doubt that there might be a co-infection and a disease might be underdiagnosed.[2] Also, it is possible that malaria might be a recurrence, not a newly acquired infection, and co-manifest with COVID-19.[3] When hydroxychloroquine is used for the management of COVID-19, it might also manage malaria co-infection in some cases and co-infection might be finally underdiagnosed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  3 in total

1.  Co-infection of COVID-19 and recurrent malaria.

Authors:  Angelita Pusparani; Joshua Henrina; Alius Cahyadi
Journal:  J Infect Dev Ctries       Date:  2021-05-31       Impact factor: 0.968

2.  COVID-19 and Plasmodium vivax malaria co-infection.

Authors:  Sundus Sardar; Rohit Sharma; Tariq Yousef Mohammad Alyamani; Mohamed Aboukamar
Journal:  IDCases       Date:  2020-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.